Author

Kyoungtea Kim

University of North Carolina at Chapel HillORCID 0000-0002-5235-0489Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

Alexander V. KabanoviD· 2 shared Andrey P. TikunoviD· 1 shared Arpan PradhaniD· 1 shared Ayse Baysal· 1 shared Chaemin LimiD· 1 shared Colin M. BashamiD· 1 shared Cynthia L. Winham· 1 shared Dalia HaydariD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Alexander V. KabanovORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Myeloid compartment reprogramming through nanoparticle delivered resiquimod blocks paracrine growth support and activates phagocytosis to slow tumor progression in endogenous mouse medulloblastoma and diffuse midline glioma models

Leon McSwain, Kyoungtea Kim, Duhyeong Hwang, Chaemin Lim, Cynthia L. Winham, Jon Jacques, Hunter C. Jonus, Elias P. Rosen, Arpan Pradhan, Sudhir Pai Kasturi, Andrey P. Tikunov, Serge Yacoub, Dalia Haydar, Alexander V. Kabanov, Jessica Raper, , Marina Sokolsky‐Papkov

ResiPOx, a nanoparticle-delivered TLR7/8 agonist, reprograms tumor-associated myeloid cells to inhibit tumor growth in mouse models of medulloblastoma and diffuse midline glioma.

bioRxiv · May 8, 2026 · PreprintCancer Biology

PEG-Free Tunable Poly(2-Oxazoline) Lipids Modulate LNP Biodistribution and Expression In Vivo after Intramuscular Administration

Colin M. Basham, Matt Haney, Yuling Zhao, Konstantin A. Lukyanov, Kyoungtea Kim, Ayse Baysal, Hallie Hutsell, Alexander V. Kabanov, Jacob D. Ramsey

This study develops PEG-free poly(2-oxazoline) lipids for LNPs, showing improved transfection, reduced liver accumulation, and enhanced immune tissue targeting in vivo.

bioRxiv · Jun 5, 2025 · PreprintBioengineering